Voluntary nationwide recall: Potassium (Glenmark – June)

Jul. 2024Pharmacy Updates

Glenmark Pharmaceuticals Inc. is recalling 114 batches of Potassium Chloride Extended-Release Capsules, USP (750 mg) 10 mEq K. Potassium Chloride is used for the treatment of low potassium.

This drug is being recalled because the product failed to dissolve in the body. This may cause high potassium levels, which can result in irregular heartbeat that can lead to cardiac arrest.

As of the date of Glenmark’s recall announcement, June 24, 2024, there have been no reports of adverse events related to this recall. Consult your health care provider before you stop using this product. To see if your medication was recalled, contact your doctor or pharmacy where you received the medication or visit the FDA website below.

To learn more about this recall, you can take one or more of the steps below.

  • Talk to your doctor or pharmacist.
  • Call Inmar Rx Solutions at 1-877-883-9273. TTY users should call 711. Help is available Monday through Friday from 9 a.m. to 5 p.m. EST.
  • Visit the FDA website.

Recent Announcements

CME Webinar: American Foundation for Suicide Prevention’s ‘Talk Saves Lives’ Program

Please join us on Tuesday, April 28, from noon to 1 p.m. for “Talk Saves Lives: An Introduction to Suicide Prevention.” This live, CME-accredited webinar is the American Foundation for Suicide Prevention’s flagship suicide prevention education program. It covers the scope of this leading cause of death, warning signs and risk factors for suicide, and strategies to prevent it.
Feb. 2026Education/Webinars

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.
Jan. 2026Education/Webinars

Provider Directory Updates and Required Attestation

As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).
Jan. 2026Important Notices